MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 18, 2007; DOI: 10.1124/mol.107.036145


0026-895X/07/7203-753-760$20.00
Mol Pharmacol 72:753-760, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.036145v1
72/3/753    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chakrabarti, S.
Right arrow Articles by Gintzler, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chakrabarti, S.
Right arrow Articles by Gintzler, A. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*MORPHINE

Phosphorylation of G{alpha}s Influences Its Association with the µ-Opioid Receptor and Is Modulated by Long-Term Morphine Exposure

Sumita Chakrabarti, and Alan R. Gintzler

Department of Biochemistry, State University of New York, Downstate Medical Center, Brooklyn, New York

The recent biochemical demonstration of the association of the µ-opioid receptor (MOR) with G{alpha}s that increases after long-term morphine treatment (Mol Brain Res 135:217–224, 2005) provides a new imperative for studying MOR-G{alpha}s interactions and the mechanisms that modulate it. A persisting challenge is to elucidate those neurochemical parameters modulated by long-term morphine treatment that facilitate MOR-G{alpha}s association. This study demonstrates that 1) G{alpha}s exists as a phosphoprotein, 2) the stoichiometry of G{alpha}s phosphorylation decreases after long-term morphine treatment, and 3) in vitro dephosphorylation of G{alpha}s increases its association with MOR. Furthermore, our data suggest that increased association of G{alpha}s with protein phosphatase 2A is functionally linked to the long-term morphine treatment-induced reduction in G{alpha}s phosphorylation. These findings are observed in MOR-Chinese hamster ovary and F11 cells as well as spinal cord, indicating that they are not idiosyncratic to the particular cell line used or a "culture" phenomenon and generalize to complex neural tissue. Taken together, these results indicate that the phosphorylation state of G{alpha}s is a critical determinant of its interaction with MOR. Long-term morphine treatment decreases G{alpha}s phosphorylation, which is a key mechanism underlying the previously demonstrated increased association of MOR and G{alpha}s in opioid tolerant tissue.


Received for publication March 19, 2007.

Accepted for publication June 15, 2007.

Address correspondence to: Dr. Alan Gintzler, Box 8, Department of Biochemistry, SUNY Downstate Medical Center, 450 Clarkson Ave., Brooklyn, NY 11203. E-mail: alan.gintzler{at}downstate.edu




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
P. Fan, Z. Jiang, I. Diamond, and L. Yao
Up-Regulation of AGS3 during Morphine Withdrawal Promotes cAMP Superactivation via Adenylyl Cyclase 5 and 7 in Rat Nucleus Accumbens/Striatal Neurons
Mol. Pharmacol., September 1, 2009; 76(3): 526 - 533.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. R. Gintzler and S. Chakrabarti
The Ambiguities of Opioid Tolerance Mechanisms: Barriers to Pain Therapeutics or New Pain Therapeutic Possibilities
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 709 - 713.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Shy, S. Chakrabarti, and A. R. Gintzler
Plasticity of Adenylyl Cyclase-Related Signaling Sequelae after Long-Term Morphine Treatment
Mol. Pharmacol., March 1, 2008; 73(3): 868 - 879.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics